Back

Latest Forum Topics / Alset    Last:0.021    +0.001

Post Reply

Alset International (SeD) The new beginning Post Reply Rate topic
gregtan123 Supreme	20-Jan-2021 23:10        gregtan123 About Contact  Quote this Post!
x 0   x 0  Alert Admin	yeah chan n son should tio covid n pass gokwok      ( Date: 20-Jan-2021 23:07) Posted: The public offering equates to 6,666,666 shares of the Company&rsquo s common stock at a price of $3.60 per share. The Company intends to use the net proceeds from this offering, together with their existing cash, to fund the development and growth of new business lines, acquisition opportunities, and general corporate and working capital needs. 6,666,666 literally Satan Chan meh LOL  TeoMark      ( Date: 20-Jan-2021 20:19) Posted: Issue to public ROCHESTER, N.Y., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (NYSE American: DSS) (the &ldquo Company&rdquo ), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced the pricing of an upsized underwritten public offering with gross proceeds to the Company expected to be approximately $24.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. The public offering equates to 6,666,666 shares of the Company&rsquo s common stock at a price of $3.60 per share. The Company intends to use the net proceeds from this offering, together with their existing cash, to fund the development and growth of new business lines, acquisition opportunities, and general corporate and working capital needs. The Company has also granted the underwriters a 45-day option to purchase up to an additional 15% of shares of common stock offered in the public offering to cover over-allotments, if any, which would increase the total gross proceeds of the offering to approximately $27.6 million, if exercised in full.
Useful To Me  Not Useful To Me
gokwok Senior	20-Jan-2021 23:07        gokwok About Contact  Quote this Post!
x 0   x 0  Alert Admin	The public offering equates to 6,666,666 shares of the Company&rsquo s common stock at a price of $3.60 per share. The Company intends to use the net proceeds from this offering, together with their existing cash, to fund the development and growth of new business lines, acquisition opportunities, and general corporate and working capital needs. 6,666,666 literally Satan Chan meh LOL  TeoMark      ( Date: 20-Jan-2021 20:19) Posted: Issue to public ROCHESTER, N.Y., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (NYSE American: DSS) (the &ldquo Company&rdquo ), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced the pricing of an upsized underwritten public offering with gross proceeds to the Company expected to be approximately $24.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. The public offering equates to 6,666,666 shares of the Company&rsquo s common stock at a price of $3.60 per share. The Company intends to use the net proceeds from this offering, together with their existing cash, to fund the development and growth of new business lines, acquisition opportunities, and general corporate and working capital needs. The Company has also granted the underwriters a 45-day option to purchase up to an additional 15% of shares of common stock offered in the public offering to cover over-allotments, if any, which would increase the total gross proceeds of the offering to approximately $27.6 million, if exercised in full. Alvin2042      ( Date: 20-Jan-2021 20:16) Posted: Issue to who?
Useful To Me  Not Useful To Me
Jacklim82 Member	20-Jan-2021 21:29        Jacklim82 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Useful?? https://links.sgx.com/1.0.0/corporate-announcements/MS0VT2QZ9K0MYH6L/516c06cdb58d1069cc33628c0a6ca05a2a06a1134045ea5949817a12f1efdfad
Useful To Me  Not Useful To Me
Alvin2042 Master	20-Jan-2021 20:45        Alvin2042 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Lucky never touch DSS. papayaface      ( Date: 20-Jan-2021 20:26) Posted: What nonsense. Also shares are priced at such a big discount.  Boss is really screwing eisting shareholders again and again. There' s no point holding on to the shares on a long term. Looks like its going to tank again. Good luck  TeoMark      ( Date: 20-Jan-2021 20:00) Posted: https://finance.yahoo.com/news/document-security-systems-inc-prices-013500057.html Massive dilution for DSS. Issue 6.6m  new shares priced at 3.60 with option for another 1m shares. gg to alset here
Useful To Me  Not Useful To Me
luckyfa Elite	20-Jan-2021 20:43        luckyfa About Contact  Quote this Post!
x 0   x 0  Alert Admin	US market is Big.... Who knows closing will be Green Green.... Nano9 looks 👍 .... Could be Big.... (Just my opinion)
Useful To Me  Not Useful To Me
papayaface Supreme	20-Jan-2021 20:26        papayaface About Contact  Quote this Post!   Yells: "This is the best time to enter....when everythings uncertain"
x 0   x 0  Alert Admin	What nonsense. Also shares are priced at such a big discount.  Boss is really screwing eisting shareholders again and again. There' s no point holding on to the shares on a long term. Looks like its going to tank again. Good luck  TeoMark      ( Date: 20-Jan-2021 20:00) Posted: https://finance.yahoo.com/news/document-security-systems-inc-prices-013500057.html Massive dilution for DSS. Issue 6.6m  new shares priced at 3.60 with option for another 1m shares. gg to alset here. Alvin2042      ( Date: 20-Jan-2021 19:56) Posted: Big drop in DSS sp in pre open trade on heavy volume.
Useful To Me  Not Useful To Me
TeoMark Veteran	20-Jan-2021 20:19        TeoMark About Contact  Quote this Post!
x 0   x 0  Alert Admin	Issue to public ROCHESTER, N.Y., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (NYSE American: DSS) (the &ldquo Company&rdquo ), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced the pricing of an upsized underwritten public offering with gross proceeds to the Company expected to be approximately $24.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. The public offering equates to 6,666,666 shares of the Company&rsquo s common stock at a price of $3.60 per share. The Company intends to use the net proceeds from this offering, together with their existing cash, to fund the development and growth of new business lines, acquisition opportunities, and general corporate and working capital needs. The Company has also granted the underwriters a 45-day option to purchase up to an additional 15% of shares of common stock offered in the public offering to cover over-allotments, if any, which would increase the total gross proceeds of the offering to approximately $27.6 million, if exercised in full. Alvin2042      ( Date: 20-Jan-2021 20:16) Posted: Issue to who? TeoMark      ( Date: 20-Jan-2021 20:00) Posted: https://finance.yahoo.com/news/document-security-systems-inc-prices-013500057.html Massive dilution for DSS. Issue 6.6m  new shares priced at 3.60 with option for another 1m shares. gg to alset here
Useful To Me  Not Useful To Me
Alvin2042 Master	20-Jan-2021 20:16        Alvin2042 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Issue to who? TeoMark      ( Date: 20-Jan-2021 20:00) Posted: https://finance.yahoo.com/news/document-security-systems-inc-prices-013500057.html Massive dilution for DSS. Issue 6.6m  new shares priced at 3.60 with option for another 1m shares. gg to alset here. Alvin2042      ( Date: 20-Jan-2021 19:56) Posted: Big drop in DSS sp in pre open trade on heavy volume.
Useful To Me  Not Useful To Me
TeoMark Veteran	20-Jan-2021 20:00        TeoMark About Contact  Quote this Post!
x 0   x 0  Alert Admin	https://finance.yahoo.com/news/document-security-systems-inc-prices-013500057.html Massive dilution for DSS. Issue 6.6m  new shares priced at 3.60 with option for another 1m shares. gg to alset here. Alvin2042      ( Date: 20-Jan-2021 19:56) Posted: Big drop in DSS sp in pre open trade on heavy volume. Alvin2042      ( Date: 20-Jan-2021 19:54) Posted: https://www.marketwatch.com/investing/stock/ds
Useful To Me  Not Useful To Me
Alvin2042 Master	20-Jan-2021 19:56        Alvin2042 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Big drop in DSS sp in pre open trade on heavy volume. Alvin2042      ( Date: 20-Jan-2021 19:54) Posted: https://www.marketwatch.com/investing/stock/dss gregtan123      ( Date: 20-Jan-2021 19:34) Posted: Just releaase on SGX, can follow new silkroutes genomic huawei and 2.7x in ONE Day? DSS Expands Nutraceutical Product Lines through Impact BioMedical&rsquo s Investment in Nano Nutraceutical Contract Manufacturer Nano9 Rochester, N.Y., January 19, 2021 - Document Security Systems, Inc. (&ldquo DSS&rdquo or the &ldquo Company&rdquo ) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. (&ldquo Impact BioMedical&rdquo ) entered into an investment and distribution agreement with Nano9 Labs, LLC (&ldquo Nano9&rdquo ), an R& D and contract manufacturing company specializing in the development of nano-sized nutraceutical products and ingredients. &ldquo Impact BioMedical&rsquo s investment in Nano9 will enable us to add multiple private-labeled nutraceutical product lines to our RBC Life and HWH World subsidiaries,&rdquo stated Frank D. Heuszel, CEO of DSS. &ldquo We expect Nano9&rsquo s nutraceutical delivery technology to greatly strengthen the competitive advantage of our growing direct marketing distributor network, both in the U.S. and across Asia. Our direct selling segment was a key driver of revenue growth for DSS in 2020, and we expect this trend to accelerate in 2021 and beyond.&rdquo &ldquo Nano9 is very excited about the newly formed relationship with Impact BioMedical," said founder Dr. Tracy Gibbs. &ldquo Our technology and product lines are growing fast in the U.S. With this new partnership, we can now grow and expand the benefits of nano technology in Asian markets as well.&rdquo
Useful To Me  Not Useful To Me
Alvin2042 Master	20-Jan-2021 19:54        Alvin2042 About Contact  Quote this Post!
x 0   x 0  Alert Admin	https://www.marketwatch.com/investing/stock/dss gregtan123      ( Date: 20-Jan-2021 19:34) Posted: Just releaase on SGX, can follow new silkroutes genomic huawei and 2.7x in ONE Day? DSS Expands Nutraceutical Product Lines through Impact BioMedical&rsquo s Investment in Nano Nutraceutical Contract Manufacturer Nano9 Rochester, N.Y., January 19, 2021 - Document Security Systems, Inc. (&ldquo DSS&rdquo or the &ldquo Company&rdquo ) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. (&ldquo Impact BioMedical&rdquo ) entered into an investment and distribution agreement with Nano9 Labs, LLC (&ldquo Nano9&rdquo ), an R& D and contract manufacturing company specializing in the development of nano-sized nutraceutical products and ingredients. &ldquo Impact BioMedical&rsquo s investment in Nano9 will enable us to add multiple private-labeled nutraceutical product lines to our RBC Life and HWH World subsidiaries,&rdquo stated Frank D. Heuszel, CEO of DSS. &ldquo We expect Nano9&rsquo s nutraceutical delivery technology to greatly strengthen the competitive advantage of our growing direct marketing distributor network, both in the U.S. and across Asia. Our direct selling segment was a key driver of revenue growth for DSS in 2020, and we expect this trend to accelerate in 2021 and beyond.&rdquo &ldquo Nano9 is very excited about the newly formed relationship with Impact BioMedical," said founder Dr. Tracy Gibbs. &ldquo Our technology and product lines are growing fast in the U.S. With this new partnership, we can now grow and expand the benefits of nano technology in Asian markets as well.&rdquo
Useful To Me  Not Useful To Me
gregtan123 Supreme	20-Jan-2021 19:34        gregtan123 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Just releaase on SGX, can follow new silkroutes genomic huawei and 2.7x in ONE Day? DSS Expands Nutraceutical Product Lines through Impact BioMedical&rsquo s Investment in Nano Nutraceutical Contract Manufacturer Nano9 Rochester, N.Y., January 19, 2021 - Document Security Systems, Inc. (&ldquo DSS&rdquo or the &ldquo Company&rdquo ) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. (&ldquo Impact BioMedical&rdquo ) entered into an investment and distribution agreement with Nano9 Labs, LLC (&ldquo Nano9&rdquo ), an R& D and contract manufacturing company specializing in the development of nano-sized nutraceutical products and ingredients. &ldquo Impact BioMedical&rsquo s investment in Nano9 will enable us to add multiple private-labeled nutraceutical product lines to our RBC Life and HWH World subsidiaries,&rdquo stated Frank D. Heuszel, CEO of DSS. &ldquo We expect Nano9&rsquo s nutraceutical delivery technology to greatly strengthen the competitive advantage of our growing direct marketing distributor network, both in the U.S. and across Asia. Our direct selling segment was a key driver of revenue growth for DSS in 2020, and we expect this trend to accelerate in 2021 and beyond.&rdquo &ldquo Nano9 is very excited about the newly formed relationship with Impact BioMedical," said founder Dr. Tracy Gibbs. &ldquo Our technology and product lines are growing fast in the U.S. With this new partnership, we can now grow and expand the benefits of nano technology in Asian markets as well.&rdquo
Useful To Me  Not Useful To Me
Eatall Veteran	20-Jan-2021 16:50        Eatall About Contact  Quote this Post!
x 0   x 0  Alert Admin	No action, thats y i sold off half away liao..at a loss Waiting for any master to give signal buy... Then buy back... If not, let it as it is... luckyfa      ( Date: 20-Jan-2021 16:44) Posted: Really test our patience here😁 .... Cannot chan no action one...💪
Useful To Me  Not Useful To Me
luckyfa Elite	20-Jan-2021 16:44        luckyfa About Contact  Quote this Post!
x 0   x 0  Alert Admin	Really test our patience here😁 .... Cannot chan no action one...💪
Useful To Me  Not Useful To Me
Ligaya Master	20-Jan-2021 13:04        Ligaya About Contact  Quote this Post!
x 0   x 0  Alert Admin	medical technology ah? chan must wayang with logic anyway avarga' s taiga building products, the positive report on it' s US operations bodes well for Alset' s two housing projects luckyfa      ( Date: 20-Jan-2021 11:29) Posted: The latest move has make the company to be in technoloy front.... Think concept similiar ti tesla?..... Technology front runner.....
Useful To Me  Not Useful To Me
luckyfa Elite	20-Jan-2021 11:29        luckyfa About Contact  Quote this Post!
x 0   x 0  Alert Admin	The latest move has make the company to be in technoloy front.... Think concept similiar ti tesla?..... Technology front runner.....
Useful To Me  Not Useful To Me
Ligaya Master	20-Jan-2021 11:17        Ligaya About Contact  Quote this Post!
x 0   x 0  Alert Admin	this nutraceutical  collaboration is at least a more compelling and practical strategy than the covid-vaccine concept  more in line with health and supplements in sync with their pan-coronavirus reseaches and direct marketing network they been buidling up dss is too small a float can ignore, chan needs to unlock dss with liquidity and dilute it  gokwok      ( Date: 20-Jan-2021 10:55) Posted: Also no use.... DSS post market closed -12.73% leh Ligaya      ( Date: 20-Jan-2021 09:19) Posted: https://www.globenewswire.com/news-release/2021/01/19/2160669/0/en/DSS-Expands-Nutraceutical-Product-Lines-through-Impact-BioMedical-s-Investment-in-Nano-Nutraceutical-Contract-Manufacturer-Nano9.html DSS Expands Nutraceutical Product Lines through Impact BioMedical&rsquo s Investment in Nano Nutraceutical Contract Manufacturer Nano9   January 19, 2021 08:45 ET  |  Source:  Document Security Systems Inc. ROCHESTER, N.Y., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (&ldquo DSS&rdquo or the &ldquo Company&rdquo ) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. (&ldquo Impact BioMedical&rdquo ) entered into an investment and distribution agreement with Nano9 Labs, LLC (&ldquo Nano9&rdquo ), an R& D and contract manufacturing company specializing in the development of nano-sized nutraceutical products and ingredients. &ldquo Impact BioMedical&rsquo s investment in Nano9 will enable us to add multiple private-labeled nutraceutical product lines to our RBC Life and HWH World subsidiaries,&rdquo stated Frank D. Heuszel, CEO of DSS. &ldquo We expect Nano9&rsquo s nutraceutical delivery technology to greatly strengthen the competitive advantage of our growing direct marketing distributor network, both in the U.S. and across Asia. Our direct selling segment was a key driver of revenue growth for DSS in 2020, and we expect this trend to accelerate in 2021 and beyond.&rdquo &ldquo Nano9 is very excited about the newly formed relationship with Impact BioMedical," said founder Dr. Tracy Gibbs. &ldquo Our technology and product lines are growing fast in the U.S. With this new partnership, we can now grow and expand the benefits of nano technology in Asian markets as well.&rdquo Nano9&rsquo s proprietary three-stage process enables the creation of nano particles out of ingredients that traditionally have low to no bioavailability. &ldquo We believe our technology represents a paradigm shift in delivery technology for the nutraceutical industry. By using nano technology, we can change the way nutrients are delivered to our cells by dramatically increasing the bioavailability of ingredients while simultaneously increasing efficacy,&rdquo added Dr. Gibbs. &ldquo Combining innovative nutraceutical products with our established direct selling infrastructure affords us the opportunity to rapidly monetize this investment, while the addition of multiple new product lines further strengthens the overall value of Impact BioMedical,&rdquo commented Jason Grady, COO of DSS. Founded in 2018, and after two years of improving its technology, Nano9 launched its first product to market in the spring of 2020. Currently Nano9 produces products for 16 companies in four countries. The U.S.  nutraceutical market  was worth approximately $71 billion in 2017 and is forecasted to reach $133 billion by 2025, according to Statista. Globally, the nutraceutical market is growing at a 7.8% CAGR and is expected to reach $336 billion by 2023, according to BCC Research.
Useful To Me  Not Useful To Me
luckyfa Elite	20-Jan-2021 11:03        luckyfa About Contact  Quote this Post!
x 0   x 0  Alert Admin	🚀 🚀 🚀 gokwok      ( Date: 20-Jan-2021 10:55) Posted: Also no use.... DSS post market closed -12.73% leh Ligaya      ( Date: 20-Jan-2021 09:19) Posted: https://www.globenewswire.com/news-release/2021/01/19/2160669/0/en/DSS-Expands-Nutraceutical-Product-Lines-through-Impact-BioMedical-s-Investment-in-Nano-Nutraceutical-Contract-Manufacturer-Nano9.html DSS Expands Nutraceutical Product Lines through Impact BioMedical&rsquo s Investment in Nano Nutraceutical Contract Manufacturer Nano9   January 19, 2021 08:45 ET  |  Source:  Document Security Systems Inc. ROCHESTER, N.Y., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (&ldquo DSS&rdquo or the &ldquo Company&rdquo ) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. (&ldquo Impact BioMedical&rdquo ) entered into an investment and distribution agreement with Nano9 Labs, LLC (&ldquo Nano9&rdquo ), an R& D and contract manufacturing company specializing in the development of nano-sized nutraceutical products and ingredients. &ldquo Impact BioMedical&rsquo s investment in Nano9 will enable us to add multiple private-labeled nutraceutical product lines to our RBC Life and HWH World subsidiaries,&rdquo stated Frank D. Heuszel, CEO of DSS. &ldquo We expect Nano9&rsquo s nutraceutical delivery technology to greatly strengthen the competitive advantage of our growing direct marketing distributor network, both in the U.S. and across Asia. Our direct selling segment was a key driver of revenue growth for DSS in 2020, and we expect this trend to accelerate in 2021 and beyond.&rdquo &ldquo Nano9 is very excited about the newly formed relationship with Impact BioMedical," said founder Dr. Tracy Gibbs. &ldquo Our technology and product lines are growing fast in the U.S. With this new partnership, we can now grow and expand the benefits of nano technology in Asian markets as well.&rdquo Nano9&rsquo s proprietary three-stage process enables the creation of nano particles out of ingredients that traditionally have low to no bioavailability. &ldquo We believe our technology represents a paradigm shift in delivery technology for the nutraceutical industry. By using nano technology, we can change the way nutrients are delivered to our cells by dramatically increasing the bioavailability of ingredients while simultaneously increasing efficacy,&rdquo added Dr. Gibbs. &ldquo Combining innovative nutraceutical products with our established direct selling infrastructure affords us the opportunity to rapidly monetize this investment, while the addition of multiple new product lines further strengthens the overall value of Impact BioMedical,&rdquo commented Jason Grady, COO of DSS. Founded in 2018, and after two years of improving its technology, Nano9 launched its first product to market in the spring of 2020. Currently Nano9 produces products for 16 companies in four countries. The U.S.  nutraceutical market  was worth approximately $71 billion in 2017 and is forecasted to reach $133 billion by 2025, according to Statista. Globally, the nutraceutical market is growing at a 7.8% CAGR and is expected to reach $336 billion by 2023, according to BCC Research.
Useful To Me  Not Useful To Me
gokwok Senior	20-Jan-2021 10:57        gokwok About Contact  Quote this Post!
x 0   x 0  Alert Admin	I small retailer leh boss. Give chance pls haha need Towkay Chan to push  Deepimpact      ( Date: 20-Jan-2021 10:46) Posted: You push lor ! If wan to move, long ago move already gokwok      ( Date: 19-Jan-2021 11:10) Posted: Wa ALSET really sibei cui. New silkroutes today alone up 200% liao. ALSET not even moving LOL jok
Useful To Me  Not Useful To Me
gokwok Senior	20-Jan-2021 10:55        gokwok About Contact  Quote this Post!
x 0   x 0  Alert Admin	Also no use.... DSS post market closed -12.73% leh Ligaya      ( Date: 20-Jan-2021 09:19) Posted: https://www.globenewswire.com/news-release/2021/01/19/2160669/0/en/DSS-Expands-Nutraceutical-Product-Lines-through-Impact-BioMedical-s-Investment-in-Nano-Nutraceutical-Contract-Manufacturer-Nano9.html DSS Expands Nutraceutical Product Lines through Impact BioMedical&rsquo s Investment in Nano Nutraceutical Contract Manufacturer Nano9   January 19, 2021 08:45 ET  |  Source:  Document Security Systems Inc. ROCHESTER, N.Y., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (&ldquo DSS&rdquo or the &ldquo Company&rdquo ) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. (&ldquo Impact BioMedical&rdquo ) entered into an investment and distribution agreement with Nano9 Labs, LLC (&ldquo Nano9&rdquo ), an R& D and contract manufacturing company specializing in the development of nano-sized nutraceutical products and ingredients. &ldquo Impact BioMedical&rsquo s investment in Nano9 will enable us to add multiple private-labeled nutraceutical product lines to our RBC Life and HWH World subsidiaries,&rdquo stated Frank D. Heuszel, CEO of DSS. &ldquo We expect Nano9&rsquo s nutraceutical delivery technology to greatly strengthen the competitive advantage of our growing direct marketing distributor network, both in the U.S. and across Asia. Our direct selling segment was a key driver of revenue growth for DSS in 2020, and we expect this trend to accelerate in 2021 and beyond.&rdquo &ldquo Nano9 is very excited about the newly formed relationship with Impact BioMedical," said founder Dr. Tracy Gibbs. &ldquo Our technology and product lines are growing fast in the U.S. With this new partnership, we can now grow and expand the benefits of nano technology in Asian markets as well.&rdquo Nano9&rsquo s proprietary three-stage process enables the creation of nano particles out of ingredients that traditionally have low to no bioavailability. &ldquo We believe our technology represents a paradigm shift in delivery technology for the nutraceutical industry. By using nano technology, we can change the way nutrients are delivered to our cells by dramatically increasing the bioavailability of ingredients while simultaneously increasing efficacy,&rdquo added Dr. Gibbs. &ldquo Combining innovative nutraceutical products with our established direct selling infrastructure affords us the opportunity to rapidly monetize this investment, while the addition of multiple new product lines further strengthens the overall value of Impact BioMedical,&rdquo commented Jason Grady, COO of DSS. Founded in 2018, and after two years of improving its technology, Nano9 launched its first product to market in the spring of 2020. Currently Nano9 produces products for 16 companies in four countries. The U.S.  nutraceutical market  was worth approximately $71 billion in 2017 and is forecasted to reach $133 billion by 2025, according to Statista. Globally, the nutraceutical market is growing at a 7.8% CAGR and is expected to reach $336 billion by 2023, according to BCC Research.
Useful To Me  Not Useful To Me

                                                         First   < Newer   2521-2540 of 7727   Older>   Last